top of page
Starting August 1, 2024, Quickarrays, Inc. will be providing all products and services in place of Pantomics Inc.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
MET181
Metastatic cancer tissue array, set 1, 18 cases of metastatic cancers from 4 major anatomic sites/organs, 7 cases overlapped with MET182.
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$229
1 slide
In-Stock
A | |
B | |
C | |
D | |





Human
18
18
2.5mm
4um
4
5
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in metastasis of various cancers.

ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
---|---|---|---|---|---|---|---|
A01 | F | 56 | Lymph node | Metastatic breast carcinoma | |||
A02 | F | 41 | Lymph node | Metastatic breast carcinoma | |||
A03 | F | 73 | Lymph node | Metastatic breast carcinoma | |||
A04 | F | 52 | Lymph node | Metastatic colon adenocarcinoma | |||
A05 | F | 47 | Lymph node | Metastatic colon adenocarcinoma | |||
B01 | M | 69 | Lung | Metastatic cancers, from gastrointestional site? | |||
B02 | F | 43 | Ovary | Metastatic colon adenocarcinoma | |||
B03 | F | 57 | Lymph node | Metastatic gastric adenocarcinoma | |||
B04 | M | 56 | Lymph node | Metastatic gastric adenocarcinoma | |||
B05 | M | 70 | Lymph node | Metastatic gastric adenocarcinoma | |||
C01 | M | 46 | Lymph node | Metastatic lung squamous cell carcinoma | |||
C02 | M | 35 | Lymph node | Metastatic lung squamous cell carcinoma | |||
C03 | M | 69 | Lymph node | Metastatic lung adenocarcinoma | |||
C04 | M | 60 | Lymph node | Metastatic lung adenocarcinoma | |||
C05 | F | 40 | Lymph node | Metastatic nasopharygeal carcinoma | |||
D01 | M | 66 | Lymph node | Metastatic rectal adenocarcinoma | |||
D02 | F | 35 | Ovary | Metastatic rectal adenocarcinoma | |||
D03 | F | 56 | Lymph node | Metastatic thyroid adenocarcinoma | |||
null |
bottom of page